Aptar Expands Component ManufacturingBy
Part of the special news roundup of DCAT member companies for the DCAT Week ’17 Special Edition of DCAT Value Chain Insights (April 5, 2017)
Aptar Pharma has added to its manufacturing capabilities for injectable elastomeric components with an expansion at its facility in Congers, New York. The newly expanded manufacturing capabilities will be used to complete premium injectable elastomeric component manufacturing in North America.
The new expansion supports the company’s growth in three directions by adding capacity to the company’s network of global manufacturing sites; adding equipment with the latest technologies to meet growing quality requirements; and improving service and responsiveness for its North American business operations.
Source: Aptar Pharma